MAPT and Parkinson disease: Several proteins that were already known to be involved in PD have been investigated in CSF as potential biomarkers for diagnosis, disease progression, or cognitive decline, such as α-syn, neurofilament light chain (NFL), DJ-1, tau, and amyloid β42 (reviewed in [5]).